| Literature DB >> 31071141 |
Mahdieh Abbasalizad Farhangi1,2, Leila Nikniaz3, Zeinab Nikniaz4.
Abstract
BACKGROUND: In the current meta-analysis, we aimed to systematically review and summarize the eligible studies evaluating the association between dietary acid load in terms of potential renal acid load (PRAL) and net-endogenous acid production (NEAP) with anthropometric parameters and serum lipids in adult population.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31071141 PMCID: PMC6508739 DOI: 10.1371/journal.pone.0216547
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The PICO criteria used for the present systematic review.
| PICO criteria | Description |
|---|---|
| Participants | General adult population |
| Exposure (Interventions) | Highest category of dietary acid load represented by higher scores of PRAL or NEAP |
| Comparisons | Lowest category of dietary acid load represented by higher scores of PRAL or NEAP |
| Outcome | BMI, WC, TG, LDL, TC, HDL, obesity prevalence |
| Study design | Observational studies with the design of cross-sectional, case control or cohort |
Fig 1Flow diagram of study screening and selection process.
Characteristics of studies included in the systematic review owing to reporting the association between dietary acid load with general and central obesity indices and the prevalence of obesity.
| First author | Year | Country | Study design | Sex | Age range | Sample size / Population | Number of cases / controls | Dietary assessment/index | Result | Adjusted variables | Quality of the study |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Akter S [ | 2014 | Japan | Cross-sectional | Both | 18–70 y | 2028/ working population | 676/ 676 | BDHQ/ PRAL, NEAP | No difference was found between BMI and PRAL or NEAP tertiles. | Age, sex | 8 |
| Akter S [ | 2016 | Japan | Cross-sectional | Both | 19–69 y | 1732 | 433/433 | BDHQ/ PRAL | No significant difference between BMI in different quartiles of PRAL. | - | 6 |
| Akter S [ | 2015 | Japan | Cross-sectional | Men | 45–75 y | 27808 | 6952/6952 | 147-item FFQ /PRAL | BMI in lowest quartile of PRAL was higher than the highest (P = 0.01) | - | 6 |
| Akter S [ | 2015 | Japan | Cross-sectional | Women | 45–75 y | 36851 | 9213/9213 | 147-item FFQ/PRAL | BMI in the highest quartile of the PRAL was higher than the lowest (P < 0.001) | - | 6 |
| Akter S [ | 2017 | Japan | Cross-sectional | Both | 45–75 y | 92478 | 23119/23120 | 147-item FFQ/ PRAL | BMI in the highest quartiles of PRAL was significantly higher than the lowest (P <0.001) | - | 6 |
| Amodu A [ | 2013 | USA | Cross-sectional | Both | ≥ 20 y | 13274 | 2490/2477 | 24-hour dietary recall questionnaire/NEAP | The prevalence of obesity in highest quartile of NEAP was significantly higher than the lowest (35.9 vs 24.8 P <0.001) | - | 7 |
| Bahadoran Z [ | 2015 | Iran | Cross-sectional | Both | 19–70 y | 5620 | 1405/1405 | 147-item FFQ/ PRAL | BMI and WC and the prevalence of abdominal obesity in the highest quartile of PRAL was significantly higher than the lowest. | - | 6 |
| Banerjee T [ | 2018 | USA | Cross-sectional | Both | 21–84 y | 3257 | 1074/1075 | FFQ/ PRAL | BMI in the highest tertile of PRAL was significantly higher than the lowest (P = 0.0002) | - | 7 |
| Chan R [ | 2015 | China | Cross-sectional | Both | ≥ 65y | 3122 | 780/779 | FFQ/NEAP | No significant difference in the BMI in different quartiles of NEAP was reported. | - | 7 |
| Engberink MF [ | 2012 | Netherland | Cross-sectional | Both | ≥ 55 y | 2241 | 747/747 | FFQ/ PRAL | Mean BMI and the prevalence of overweight or obesity was higher in the highest versus lowest PRAL tertile. | - | 6 |
| Fagherazzi G [ | 2014 | France | Cohort- baseline data for BMI | Women | 40-65y | 66485 | 16621/16622 | 208-item diet-history questionnaire/PRAL | Mean BMI and the prevalence of overweight or obesity was higher in the highest versus lowest PRAL quartile. | - | 6 |
| Faure AM [ | 2017 | Switzerland | Cross-sectional | Men | ≥ 60 y | 117 | 29/29 | 110-item FFQ/PRAL | BMI was non-significantly higher in highest versus lowest PRAL quartiles. | - | 6 |
| Faure AM [ | 2017 | Switzerland | Cross-sectional | Women | ≥ 60 y | 130 | 32/32 | 110-item FFQ/PRAL | BMI was non-significantly higher in highest versus lowest PRAL quartiles. | - | 6 |
| Gæde J [ | 2018 | Denmark | Cohort (DCH) | Both | 50–64 y | 54651 | 10930/10931 | 192-item FFQ/PRAL | BMI was not significantly different between PRAL quintiles | - | 5 |
| Gæde J [ | 2018 | Denmark | Cross-sectional (Inter99) | Both | 30–60 y | 5631 | 1126/1127 | FFQ/PRAL | BMI was not significantly different between PRAL quintiles | - | 6 |
| Haghighatdoost F [ | 2015 | Iran | Cross-sectional | Both | Mean age 66.8 | 547 | 274/273 | FFQ/PRAL | No significant difference in the BMI, WC and the prevalence of obesity or abdominal obesity between PRAL groupings. | Protein, fat, cholesterol, fiber, whole refined grains, fruit, meat, potassium, phosphorus, beans, nuts, vegetables, BMI | 5 |
| Han E [ | 2016 | Korea | Cross-sectional | Both | 40–79 y | 11601 | 4202/3859 | One day 24-recall/ PRAL | BMI was slightly lower in highest versus lowest terrtile of PRAL. No difference in WC was observed. | - | 7 |
| Ikizler HO [ | 2016 | USA | Cross-sectional | Both | 63 | 21/21 | 3-day prospective food diaries/ NEAP | BMI was non-significantly higher in highest versus lowest NEAP tertile. | - | 7 | |
| Iwase H [ | 2015 | Japan | Cross-sectional | Both | Mean aged 65.7 ±9.3 | 149 | 74/75 | Diet history questionnaire (DHQ)/ NEAP | No significant difference in BMI in highest versus lowest PRAL score groupings was observed. | - | 6 |
| Iwase H [ | 2015 | Japan | Cross-sectional | Both | Mean aged 65.7 ±9.3 | 149 | 74/75 | Diet history questionnaire (DHQ)/ NEAP | No significant difference in BMI in highest versus lowest PRAL score groupings was observed. | - | 7 |
| Jia T [ | 2015 | Sweden | Cross-sectional | Both | ≥ 70 y | 861 | 215/ 215 | 7-day food records | No significant difference in BMI in highest versus lowest NEAP quartils was observed. | 6 | |
| Kiefte-de Jong JC [ | 2017 | USA | Cohort-NHS- median follow-up data | Women | 30–55 y | 121700 | 14974/ 11449 | FFQ/ NEAP | Higher BMI in top quintile versus lowest quintile of NEAP observed. | Age | 7 |
| Kiefte-de Jong JC [ | 2017 | USA | Cohort-NHS2- median follow-up data | Women | 25–42 y | 116430 | 13878/ 18030 | FFQ/NEAP | Higher BMI in top quintile versus lowest quintile of NEAP observed. | Age | 6 |
| Kiefte-de Jong JC [ | 2017 | USA | Cohort-HPFS- median follow-up data | Men | 40–75 y | 51529 | 7472/ 6428 | FFQ/NEAP | Higher BMI in top quintile versus lowest quintile of NEAP observed. | Age | 7 |
| Ko BJ [ | 2017 | Korea | Cross-sectional | Both | ≥ 65 y | 1369 | 342/343 | FFQ/eNEAP | No significant difference in BMI between lowest and highest eNEAP quartiles was reported. | - | 6 |
| Krupp D [ | 2018 | Germany | Cross-sectional | Both | 18–79 y | 7115 | 1358/1356 | FFQ/PRAL | No significant difference in BMI between different PRAL quintiles was observed. | - | 5 |
| Kucharska AM [ | 2018 | Poland | Cross-sectional | Men | ≥ 20 y | 2760 | 920/ 920 | 24h-recall/ NEAP | BMI and WC and the prevalence of overweight or obesity in the highest tertile of PRAL were higher than the lowest. | - | 6 |
| Kucharska AM [ | 2018 | Poland | Cross-sectional | Women | ≥ 20 y | 3409 | 1136/ 1137 | 24h-recall/ NEAP | BMI and WC and the prevalence of overweight or obesity in the highest tertile of PRAL were higher than the lowest. | - | 5 |
| Kucharska AM [ | 2018 | Poland | Cross-sectional | Men | ≥ 20 y | 2760 | 920/ 920 | 24h-recall/ PRAL | No significant difference in the BMI and WC in the lowest versus highest PRAL tertiles was observed. The prevalence of overweight or obesity in the highest tertile of PRAL was lower than the lowest. | - | 7 |
| Kucharska AM [ | 2018 | Poland | Cross-sectional | Women | ≥ 20 y | 3409 | 1136/ 1137 | 24h-recall/ PRAL | BMI and WC and the prevalence of overweight or obesity in the highest tertile of PRAL were lower than the lowest. | - | 5 |
| Luis D [ | 2014 | Sweden | Cross-sectional | Both | 70–71 y | 673 | 224/ 224 | 7-d food records/PRAL | No significant difference in BMI between tertiles of PRAL was observed. | - | 6 |
| Murakami K [ | 2008 | Japan | Cross-sectional | Both | 18–22 y | 1136 | 227/ 227 | DHQ/ PRAL | No significant difference in BMI between quintiles of PRAL was observed. WC in the highest quintile was significantly higher than the lowest. | Residential block, residential area size, survey year, PA current smoking, | 8 |
| Rebholz CM [ | 2015 | USA | Cross-sectional | Both | 45–64 y | 15055 | 3011 | FFQ/NEAP, PRAL | The prevalence of overweight or obesity in the highest quartile was significantly higher than the lowest (73.9 vs 59.5%) | - | 6 |
| Welch AA [ | 2007 | UK | Cross-sectional | Men | 42–82 y | 6375 | 1275/ 1275 | FFQ/ PRAL | No significant difference in BMI between quintiles of PRAL was observed. | - | 6 |
| Welch AA [ | 2007 | UK | Cross-sectional | Women | 42–82 y | 8188 | 1639/1640 | FFQ/ PRAL | No significant difference in BMI between quintiles of PRAL was observed. | 6 | |
| Welch AA [ | 2013 | UK | Cross-sectional | Women | 18–79 y | 2689 | 538/ 537 | FFQ/ PRAL | No significant difference in BMI between quintiles of PRAL was observed. | - | 5 |
| Wynn E [ | 2008 | Swiss | Cross-sectional | Women | ≥ 75 y | 401 | 133/134 | FFQ/ NEAP | No significant difference in BMI between tertiles of NEAP was observed. | - | 5 |
| Hong Xu [ | 2016 | Sweden | Cross-sectional | Women | 45–84 y | 36470 | 7294/ 7294 | FFQ/ PRAL | No significant difference in BMI between quintiles of PRAL was observed. | - | 5 |
| Hong Xu [ | 2016 | Sweden | Cross-sectional | Men | 45–84 y | 44957 | 9038/ 8984 | FFQ/ PRAL | No significant difference in BMI between quintiles of PRAL was observed. | - | 6 |
| Hong Xu [ | 2016 | Sweden | Cross-sectional | Both | 70–71 y | 911 | 304/ 303 | 7-d food records/PRAL | No significant difference in BMI between tertiles of PRAL was observed. | — | 5 |
Characteristics of studies included in the systematic review owing to reporting the association between dietary acid load with serum lipids and risk of CVD, hyperlipidemia and metabolic syndrome.
| First author | Year | Country | Study design | Sex | Age range | Sample size / Population | Number of cases / controls | Dietary assessment/ index | Result | Adjusted variables | Quality of the study |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amodu A [ | 2013 | USA | Cross-sectional | Both | ≥ 20 years | 13274 | 2490/2477 | 24-hour dietary recall questionnaire/ NEAP | The prevalence CVD in lowest quartile of NEAP was significantly higher than the highest (P < 0.001). | - | 6 |
| Bahadoran Z [ | 2015 | Iran | Cross-sectional | Both | 19–70 y | 5620 | 1405/1405 | 147-item food-frequency questionnaire/ PRAL | No significant difference in TG and the prevalence of hypertriglyceridemia and low HDL and the prevalence of metabolic syndrome between quartiles was reported. | - | 6 |
| Banerjee T [ | 2018 | USA | Cross-sectional | Both | 21–84 y | 3257 | 1074/1075 | FFQ | No significant difference in the prevalence of CVD was reported. | 6 | |
| Engberink MF [ | 2012 | Netherland | Cross-sectional–baseline data | Both | ≥ 55 y | 2241/ general population | 747/747 | FFQ | No significant difference in the prevalence of CHD and the mean values of HDL and TC was observed. | 7 | |
| Haghighatdoost F [ | 2015 | Iran | Cross-sectional | Both | Mena age 66.8 | 547/ general population | 274/273 | FFQ/PRAL | TG was significantly higher in higher versus lowers PRAL score groupings. | Protein, fat, cholesterol, fiber, whole refined grains, fruit, meat, potassium, phosphorus, beans, nuts, vegetables, BMI | 9 |
| Han E [ | 2016 | Korea | Cross-sectional | Both | 40–79 y | 11601/ general population | 4202/3859 | One day 24-recall/ PRAL | TG and the prevalence of metabolic syndrome in highest tertile was significantly higher than the lowest. TC, HDL and LDL were not different. | 6 | |
| Iwase H [ | 2015 | Japan | Cross-sectional | Both | Mean aged 65.7 ±9.3 | 149/ population with T2DM | 74/75 | Diet history questionnaire (DHQ)/ PRAL | LDL, TG and the odds of metabolic syndrome in highest group of PRAL was significantly higher than the lowest. The prevalence of metabolic syndrome in lowest group of PRAL score was higher than the highest. | age, sex, serum uric acid and creatinine, total energy intake, carbohydrate intake and sodium intake. | 8 |
| Iwase H [ | 2015 | Japan | Cross-sectional | Both | Mean aged 65.7 ±9.3 | 149/ population with T2DM | 74/75 | Diet history questionnaire (HQ)/ NEAP | LDL and the odds of metabolic syndrome in highest group of PRAL was significantly higher than the lowest. | age, sex, serum uric acid and creatinine, total energy intake, carbohydrate intake and sodium intake. | 8 |
| Jia T [ | 2015 | Sweden | Cross-sectional | Both | ≥ 70 y | 861/ general population | 215/ 215 | 7-day food records/NEAP | No significant difference in the prevalence of CVD between NEAP quartiles was observed. | - | 6 |
| Kiefte-de Jong JC [ | 2017 | USA | Cohort-NHS- median follow-up data | Both | 30–55 y | 121700/ general population | 14974/ 11449 | FFQ/ NEAP, PRAL | Higher prevalence of hypercholesterolemia in highest versus lowest quintile of NEAP was reported. | Age, energy intake, BMI, family history of diabetes, menopausal status, HTN and hypercholesterolemia, smoking, alcohol intake, PA, glycemic load, AHEI index, western dietary pattern | 8 |
| Kiefte-de Jong JC [ | 2017 | USA | Cohort-NHS2- median follow-up data | Women | 25–42 y | 116430/ general population | 13878/ 18030 | FFQ/NEAP, PRAL | Higher prevalence of hypercholesterolemia in highest versus lowest quintile of NEAP was reported. | Age, energy intake, BMI, family history of diabetes, menopausal status, HTN and hypercholesterolemia, smoking, alcohol intake, PA, glycemic load, AHEI index, western dietary pattern | 8 |
| Kiefte-de Jong JC [ | 2017 | USA | Cohort-HPFS- median follow-up data | Men | 40–75 y | 51529/ general population | 7472/ 6428 | FFQ/NEAP, PRAL | Higher prevalence of hypercholesterolemia in highest versus lowest quintile of NEAP was reported. | Age, energy intake, BMI, family history of diabetes, menopausal status, HTN and hypercholesterolemia, smoking, alcohol intake, PA, glycemic load, AHEI index, western dietary pattern | 8 |
| Ko BJ [ | 2017 | Korea | Cross-sectional | Both | ≥ 65 y | 1369/ general population | 342/343 | FFQ/eNEAP | No significant difference in TG, TC, the prevalence of hyperlipidemia between lowest and highest eNEAP quartiles was reported. | - | 7 |
| Krupp D [ | 2018 | Germany | Cross-sectional | Both | 18–79 y | 7115/ general population | 1358/1356 | FFQ/PRAL | TC was lower in fifth quintile compared with the first. | - | 7 |
| Kucharska AM [ | 2018 | Poland | Cross-sectional | Men | ≥ 20 y | 2760/ general population | 920/ 920 | 24h-recall/ NEAP | TG in highest tertile of NEAP was significantly higher than the lowest. No significant difference in other parameters. | Age, sex | 8 |
| Kucharska AM [ | 2018 | Poland | Cross-sectional | Women | ≥ 20 y | 3409/ general population | 1136/ 1137 | 24h-recall/ NEAP | No significant difference in TG, TC, LDL, HDL, the prevalence of hyperlipidemia and CVD between PRAL tertiles was observed. | Age, sex | 7 |
| Kucharska AM [ | 2018 | Poland | Cross-sectional | Men | ≥ 20 y | 2760/ general population | 920/ 920 | 24h-recall/ PRAL | No significant difference in TG, TC, LDL, the prevalence of hyperlipidemia and CVD between NEAP tertiles was observed. HDL in highest tertile was significantly higher than the lowest. | Age, sex | 7 |
| Kucharska AM [ | 2018 | Poland | Cross-sectional | Women | ≥ 20 y | 3409/ general population | 1136/ 1137 | 24h-recall/ PRAL | No significant difference in TG, TC, LDL and HDL, the prevalence of hyperlipidemia and CVD between PRAL tertiles was observed. | Age, sex | 8 |
| Luis D [ | 2014 | Sweden | Cross-sectional | Both | 70–71 y | 673/ general population | 224/ 224 | 7-d food records/PRAL | No significant difference in the prevalence of dyslipidemia, CVD between tertiles of PRAL was observed. | - | 6 |
| Moghadam SKH [ | 2016 | Iran | Cross-sectional | Both | 22–80 y | 925/ general population | 224 | FFQ/ PRAL | No significant difference in LDL, HDL, TG at baseline between quartiles of PRAL was reported. | - | 6 |
| Moghadam SKH [ | 2016 | Iran | Cohort | Both | 22–80 y | 925/ general population | 224 | FFQ/ PRAL, NEAP | No significant difference in LDL, HDL, TG after three years follow-up between quartiles of PRAL was reported. | Age, sex, BMI,PA, dietary energy, fat, carbohydrate, SFA, fiber | 7 |
| Murakami K [ | 2008 | Japan | Cross-sectional | Both | 18–22 y | 1136/ general population | 227/ 227 | DHQ/ PRAL | Significantly higher values of TC, LDL between different quartiles of PRAL. No difference in HDL and TAG was observed. | Residential block, residential area size, survey year, PA current smoking, BMI, WC. | 8 |
| Berg EVD [ | 2012 | Denmark | Cross-sectional | Both | ≥ 18 y | 707/ renal transplant patients | 236/236 | FFQ/NEAP | TC in the highest tertile of NEAP was significantly lower than the lowest. No difference in the TG, HDL between tertiles of NEAP was reported. | - | 7 |
| Hong Xu [ | 2016 | Sweden | Cross-sectional | Both | 70–71 y | 911 | 304/ 303 | 7-d food records/PRAL | No significant difference in the prevalence of HLP between PRAL tertiles was observed. | Age, BMI, smoking status, PA, education, glucose disposal rate (M), CVD, HTN, HLP, energy-adjusted fiber, MUFA, PUFA, SFA, carbohydrate intake, eGFR, UAER | 8 |
Fig 2Forest plot illustrating obesity proportions in highest versus lowest PRAL categories.
Results of subgroup analyses of the association between mean difference in BMI and PRAL according to study and participants’ characteristics.
| Group | No. of studies | WMD (95% CI) | P within group | P between group | P heterogeneity | I2, % |
|---|---|---|---|---|---|---|
| 26 | 0.101–0.179, 0.380 | 0.481 | <0.001 | 99.6% | ||
| USA | 1 | 4.600 3.989 5.211 | <0.001 | - | - | |
| Denmark | 2 | 0.307 0.034 0.579 | 0.027 | <0.001 | 0.132 | 56.0% |
| Japan | 6 | -0.345–1.645 0.956 | 0.604 | <0.001 | 99.9% | |
| France | 1 | 0.100 0.030 0.170 | 0.005 | - | - | |
| UK | 3 | -0.027–0.213 0.158 | 0.772 | <0.001 | 0.0% | |
| Iran | 2 | 0.100–0.292 0.492 | 0.616 | <0.001 | 99.8 | |
| Korea | 1 | -0.100–0.233 0.033 | 0.141 | - | - | |
| Netherland | 1 | 0.400 0.055 0.745 | 0.023 | - | - | |
| Switzerland | 2 | 0.702–0.773 2.177 | 0.351 | 0.690 | 0.0% | |
| Germany | 1 | -0.600–1.131–0.069 | 0.027 | 0.164 | - | |
| Poland | 2 | -0.392–0.822 0.039 | 0.074 | 0.112 | 48.5 | |
| Sweden | 4 | 0.300 0.138 0.462 | <0.001 | 0.597 | 50.0 | |
| Europe/ USA | 17 | 0.285 0.050 0.521 | 0.017 | 0.965 | <0.001 | 94.1% |
| Asia | 9 | -0.251–0.759 0.257 | 0.333 | <0.001 | 99.9% | |
| FFQ | 17 | 0.185–0.179 0.549 | 0.320 | <0.001 | 0.320 | 99.8% |
| DHQ | 4 | 0.092 0.025 0.160 | 0.007 | 0.395 | 0.0% | |
| Food Record | 2 | -0.175–0.652 0.301 | 0.471 | 0.471 | 0.0% | |
| 24-H-Recall | 3 | -0.248–0.549 0.052 | 0.105 | 0.079 | 60.6% | |
| 1000 < | 6 | -0.100–0.133–0.066 | <0.001 | <0.001 | 0.777 | 0.0% |
| 1000–10000 | 12 | 0.309–0.066 0.683 | 0.107 | <0.001 | 95.5% | |
| >10000 | 8 | -0.200–1.007 0.607 | 0.627 | <0.001 | 99.9% | |
| Male | 6 | -0.444–2.261 1.373 | 0.632 | <0.001 | <0.001 | 99.8% |
| Female | 8 | 0.122–0.001 0.245 | 0.049 | 0.002 | 69.4% | |
| Both gender | 12 | 0.297 0.111 0.483 | 0.002 | <0.001 | 98.6% | |
Studies eligible for inclusion in the systematic review and meta-analysis
Results of subgroup analyses of the association between mean difference in BMI and NEAP according to study and participants’ characteristics.
| Group | No. of studies | WMD (95% CI) | P within group | P between group | P heterogeneity | I2, % |
|---|---|---|---|---|---|---|
| 12 | 0.845–0.106 1.797 | 0.082 | <0.001 | 99.5% | ||
| USA | 4 | 2.142 1.018 3.266 | <0.001 | <0.001 | <0.001 | 99.4% |
| China | 1 | -0.200–0.523 0.123 | 0.224 | - | - | |
| Japan | 2 | 0.112–0.159 0.384 | 0.418 | 0.670 | 0.0% | |
| Swiss | 1 | -0.900–1.020–0.780 | <0.001 | - | - | |
| Korea | 1 | 0.300–0.135 0.735 | 0.177 | - | 0.0% | |
| Poland | 2 | 1.006 0.698 1.314 | <0.001 | 0.506 | - | |
| Sweden | 1 | 0.800–0.013 1.613 | 0.054 | - | - | |
| USA | 4 | 2.142 1.018 3.266 | <0.001 | <0.001 | <0.001 | 99.4% |
| Europe | 4 | 0.457–0.827 1.742 | 0.485 | <0.001 | 97.9% | |
| Asia | 4 | 0.050–0.180 0.281 | 0.668 | 0.267 | 24.0% | |
| FFQ | 6 | 0.986–0.393 2.365 | 0.161 | <0.001 | <0.001 | 99.8% |
| DHQ | 2 | 0.112–0.159 0.384 | 0.418 | 0.670 | 0.0% | |
| 7 day-Food Record | 1 | 0.800–0.013 1.613 | 0.054 | - | - | |
| 24-H-Recall | 2 | 1.006 0.698 1.314 | <0.001 | 0.506 | 0.0% | |
| 3 day-Food Dairy | 1 | 0.900–2.911 4.711 | 0.643 | - | - | |
| 1000 < | 4 | 0.100–1.132 1.331 | 0.874 | <0.001 | <0.001 | 85.4% |
| 1000–10000 | 5 | 0.421–0.047 0.889 | 0.087 | <0.001 | 87.5% | |
| >10000 | 3 | 2.233 1.067 3.398 | <0.001 | <0.001 | 99.6% | |
| Male | 1 | 0.890 0.430 1.350 | <0.001 | <0.001 | - | - |
| Female | 2 | 0.090–1.870 2.050 | 0.928 | <0.001 | 98.8% | |
| Both gender | 9 | 1.036 0.185 1.886 | 0.017 | <0.001 | 99.1% | |
Studies eligible for inclusion in the systematic review and meta-analysis
Fig 3Forest plot illustrating obesity proportion in highest versus lowest NEAP categories.
Fig 4Forest plot illustrating weighted mean difference in BMI in highest versus lowest PRAL and NEAP.
Fig 5Forest plot illustrating weighted mean difference in WC in highest versus lowest PRAL.
Results of subgroup analyses of the association between mean difference in WC and PRAL according to study and participants’ characteristics.
| Group | No. of studies | WMD (95% CI) | P within group | P between group | P heterogeneity | I2, % |
|---|---|---|---|---|---|---|
| 6 | -0.021–1.422 1.38 | 0.977 | <0.001 | 99.8% | ||
| Japan | 1 | 0.500–0.330 1.330 | 0.238 | <0.001 | - | - |
| Iran | 2 | 0.551–1.899 3.001 | 0.660 | <0.001 | 99.9% | |
| Korea | 1 | 0.200–0.200 0.600 | 0.327 | - | - | |
| Poland | 2 | -1.000–1.568–0.432 | 0.001 | 1 | 0.0% | |
| Europe | 2 | -1.000–1.568–0.432 | <0.001 | <0.001 | 1 | 0.0% |
| Asia | 4 | 0.450–1.248 2.149 | 0.603 | <0.001 | 99.8% | |
| FFQ | 2 | 0.551–1.899 3.001 | 0.660 | <0.001 | <0.001 | 99.9% |
| DHQ | 1 | 0.500–0.330 1.330 | 0.238 | 0.003 | 82.5% | |
| 24-H-Recall | 3 | -0.544–1.457 0.368 | 0.242 | - | - | |
| <1000 | 1 | -0.700–0.809–0.591 | <0.001 | <0.001 | - | - |
| 1000–5000 | 4 | 0.100–1.591 1.791 | 0.908 | <0.001 | 97.1% | |
| >5000 | 1 | 0.200–0.200 0.600 | 0.327 | - | - | |
| Male | 1 | -1.000–1.850–0.150 | 0.021 | <0.001 | - | - |
| Female | 2 | -0.259–1.729 1.211 | 0.730 | 0.009 | 85.3% | |
| Both gender | 3 | 0.435–1.526 2.395 | 0.664 | <0.001 | 99.9% | |
Studies eligible for inclusion in the systematic review and meta-analysis
Fig 6Forest plot illustrating weighted mean difference in TC in highest versus lowest PRAL and NEAP.
Results of subgroup analyses of the association between mean difference in TC and PRAL according to study and participants’ characteristics.
| Group | No. of studies | WMD (95% CI) | P within group | P between group | P heterogeneity | I2, % |
|---|---|---|---|---|---|---|
| 6 | -0.911, 3.413 1.590 | 0.475 | 0.002 | 71.6 | ||
| Netherland | 1 | -3.860–8.566 0.846 | 0.108 | <0.001 | - | - |
| Iran | 1 | -2.200–6.634 2.234 | 0.331 | - | - | |
| Korea | 1 | 1.100–0.486 2.686 | 0.174 | - | - | |
| Germany | 1 | -7.400–11.642–3.158 | 0.001 | - | - | |
| Japan | 1 | 5.900–0.741 12.541 | 0.082 | - | - | |
| Poland | 2 | 0.271–1.990 2.533 | 0.814 | 0.311 | 2.6% | |
| Europe | 4 | -2.390–6.096 1.315 | 0.206 | 0.021 | 0.008 | 74.5% |
| Asia | 3 | 0.974–2.230 4.178 | 0.551 | 0.128 | 51.3% | |
| FFQ | 3 | -4.564–7.658–1.470 | 0.004 | <0.001 | 0.235 | 30.9% |
| DHQ | 1 | 5.900–0.741 12.541 | 0.082 | - | - | |
| 24-H-Recall | 3 | 0.821–0.472 2.113 | 0.213 | 0.501 | 0.0% | |
| <2000 | 2 | 1.457–6.443 9.358 | 0.718 | 0.066 | 0.047 | 74.7% |
| 2000–10000 | 4 | -2.390–6.096 1.315 | 0.206 | 0.008 | 74.5% | |
| >10000 | 1 | 1.100–0.486 2.686 | 0.174 | - | - | |
| Male | 1 | 1.550–1.786 4.886 | 0.362 | 0.511 | - | - |
| Female | 2 | 0.361–2.374 3.096 | 0.796 | 0.073 | 68.9% | |
| Both gender | 4 | -0.474–1.823 0.876 | 0.492 | 0.001 | 81.9% | |
Studies eligible for inclusion in the systematic review and meta-analysis
Results of subgroup analyses of the association between mean difference in TC and NEAP according to study and participants’ characteristics.
| I2, % | ||||||
|---|---|---|---|---|---|---|
| 4 | -2.071 4.549, 0.408 | 0.149 | <0.001 | 89.2% | ||
| Korea | 1 | -5.000–10.210 0.210 | 0.060 | <0.001 | - | - |
| Denmark | 1 | -15.460–21.076–9.844 | <0.001 | 0.498 | 0.0% | |
| Poland | 2 | 0.303–1.928 2.534 | 0.790 | - | - | |
| Europe | 3 | -4.520–12.514 3.473 | 0.268 | 0.216 | <0.001 | 92.5% |
| Asia | 1 | -5.000–10.210 0.210 | 0.060 | - | - | |
| FFQ | 2 | -0.316–0.662 0.030 | 0.073 | <0.001 | 0.003 | 88.3% |
| 24-H-Recall | 2 | 0.008–0.053 0.069 | 0.790 | 0.498 | 0.0% | |
| <1500 | 2 | -0.316–0.662 0.030 | 0.073 | <0.001 | 0.003 | 88.3% |
| >1500 | 2 | 0.008–0.053 0.069 | 0.790 | 0.498 | 0.0% | |
| Male | 1 | 0.032–0.060 0.123 | 0.496 | <0.001 | - | - |
| Female | 1 | -0.011–0.093 0.072 | 0.799 | - | - | |
| Both gender | 2 | -0.316–0.662 0.030 | 0.073 | 0.003 | 88.3% | |
Studies eligible for inclusion in the systematic review and meta-analysis
Fig 7Forest plot illustrating weighted mean difference in TG in highest versus lowest PRAL and NEAP.
Results of subgroup analyses of the association between mean difference in TG and PRAL according to study and participants’ characteristics.
| Group | No. of studies | WMD (95% CI) | P within group | P between group | P heterogeneity | I2, % |
|---|---|---|---|---|---|---|
| 9 | 3.468–0.231, 7.166 | 0.04 | 0.001 | 75.7% | ||
| Iran | 4 | 4.990–3.397 13.377 | 0.244 | 0.012 | 0.001 | 81.2% |
| Korea | 1 | 5.900 1.180 10.620 | 0.014 | - | - | |
| Japan | 2 | 16.111–16.365 48.586 | 0.331 | 0.014 | 83.5% | |
| Poland | 2 | 0.000–3.912 3.912 | 1.000 | 1.000 | 0.0% | |
| FFQ | 4 | 4.990–3.397 13.377 | 0.244 | 0.025 | <0.001 | 81.2% |
| DHQ | 2 | 16.111–16.365 48.586 | 0.331 | 0.014 | 83.5% | |
| 24-H-Recall | 3 | 2.205–1.841 6.251 | 0.286 | 0.169 | 43.8% | |
| <1000 | 5 | 8.291 0.495 16.086 | 0.037 | <0.001 | 0.025 | 64.0% |
| 1000–5000 | 2 | 0.000–3.912 3.912 | 1.000 | 1.000 | 0.0% | |
| >5000 | 2 | 2.030–4.681 8.742 | 0.553 | 0.004 | 87.8% | |
| Male | 1 | 0.000–5.849 5.849 | 1.000 | 0.568 | - | - |
| Female | 2 | 0.949–2.773 4.671 | 0.617 | 0.617 | 0.0% | |
| Both gender | 6 | 6.719 0.035 13.403 | 0.049 | <0.001 | 84.1% | |
Studies eligible for inclusion in the systematic review and meta-analysis
Results of subgroup analyses of the association between mean difference in TG and NEAP according to study and participants’ characteristics.
| Group | No. of studies | WMD (95% CI) | P within group | P between group | P heterogeneity | I2, % |
|---|---|---|---|---|---|---|
| 5 | 2.861–2.034, 7.756 | 0.252 | 0.180 | 36.2% | ||
| Denmark | 1 | -0.890–15.739 13.959 | 0.906 | 0.107 | - | - |
| Korea | 1 | 5.000–3.734 13.734 | 0.262 | - | - | |
| Japan | 1 | 35.430 7.536 63.324 | 0.013 | - | - | |
| Poland | 2 | 1.278–3.752 6.309 | 0.618 | 0.863 | 0.0% | |
| FFQ | 2 | 3.486–4.043 11.015 | 0.364 | 0.06 | 0.503 | 0.0% |
| DHQ | 1 | 35.430 7.536 63.324 | 0.013 | - | - | |
| 24-H-Recall | 2 | 1.278–3.752 6.309 | 0.618 | 0.863 | 0.0% | |
| <1500 | 3 | 5.655–1.614 12.924 | 0.127 | 0.332 | 0.076 | 61.1% |
| >1500 | 2 | 1.278–3.752 6.309 | 0.618 | 0.863 | 0.0% | |
| Male | 1 | 1.770–5.751 9.291 | 0.645 | 0.615 | - | - |
| Female | 1 | 0.880–5.887 7.647 | 0.799 | - | - | |
| Both gender | 3 | 8.403–5.925 22.730 | 0.250 | 0.076 | 61.1% | |
Studies eligible for inclusion in the systematic review and meta-analysis
Fig 8Forest plot illustrating weighted mean difference in HDL in highest versus lowest PRAL and NEAP.
Fig 9Forest plot illustrating weighted mean difference in LDL in highest versus lowest PRAL and NEAP.
Results of subgroup analyses of the association between mean difference in LDL and PRAL according to study and participants’ characteristics.
| Group | No. of studies | WMD (95% CI) | P within group | P between group | P heterogeneity | I2, % |
|---|---|---|---|---|---|---|
| 8 | 0.144–2.251, 1.96 | 0.893 | 0.016 | 59.5 | ||
| Iran | 3 | -3.862–7.122–0.601 | 0.020 | 0.003 | 0.348 | 5.3% |
| Korea | 1 | 0.000–1.414 1.414 | 1.000 | - | - | |
| Japan | 2 | 6.385 1.986 10.783 | 0.004 | 0.749 | 0.0% | |
| Poland | 2 | -0.093–2.359 2.173 | 0.936 | 0.252 | 23.8% | |
| FFQ | 3 | -3.862–7.122–0.601 | 0.020 | <0.001 | 0.348 | 5.3% |
| DHQ | 2 | 6.385 1.986 10.783 | 0.004 | 0.749 | 0.0% | |
| 24-H-Recall | 3 | -0.041–1.191 1.108 | 0.944 | 0.517 | 0.0% | |
| <1000 | 4 | -2.080–7.087 2.926 | 0.415 | 0.168 | 0.060 | 59.5% |
| 1000–10000 | 3 | 1.453–2.017 4.924 | 0.412 | 0.043 | 68.3% | |
| >10000 | 1 | 0.000–1.414 1.414 | 1.000 | - | - | |
| Male | 1 | 1.160–1.792 4.112 | 0.441 | 0.538 | - | - |
| Female | 2 | 2.096–4.892 9.084 | 0.441 | 0.013 | 83.8% | |
| Both gender | 5 | -1.476–4.839 1.887 | 0.390 | 0.042 | 59.5% | |
Studies eligible for inclusion in the systematic review and meta-analysis.
Fig 10Begg's funnel plots (with pseudo 95% CIs) of the WMD versus the se (WMD) of the association between BMI, PRAL and NEAP.
Fig 15Begg's funnel plots (with pseudo 95% CIs) of the WMD versus the se (WMD) of the association between LDL, PRAL and NEAP.